Conformis Hits Second Development and License Agreement Milestone

Conformis completed the second of three milestones in its license and development agreement with Stryker Orthopaedics, under which Conformis is developing patient-specific instrumentation (PSI) for use with Stryker’s knee joint replacement implants. Conformis will receive an additional $3.0 million from Stryker for achieving this milestone.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us